Harsha Moole, an internal medicine-trained physician-scientist, shares insights gained from his experience in healthcare venture capital. Seven years ago, Moole made his first investment in a healthcare startup, motivated by his belief that medical professionals could make more informed investment decisions than generalist financiers due to their understanding of clinical workflows, regulatory pathways, and reimbursement systems.
Recognizing a significant gap between clinical needs and investment allocation, Moole founded PhysicianEstate, a venture capital firm focused on early-stage healthcare investments including digital health, biotech, and medical devices. Thus far, he has made 22 healthcare investments, achieving a 2.16x gross Total Value to Paid-In Capital (TVPI) with a current median investment age of 3.5 years, although he anticipates future write-downs as the portfolio matures.
Moole emphasizes three critical factors that can determine the success or failure of healthcare startups: clinical necessity, regulatory feasibility, and reimbursement viability. Many general venture capitalists fail to adequately assess these elements, leading to significant investment losses.
To combat this, Moole has built a network of over 200 physicians across various specialties, enabling peer review of potential investments. This collaborative approach ensures rigorous evaluation based on clinical authority.
While Moole encourages physician participation in healthcare investing, he warns that it is not a passive endeavor and requires deep expertise. He advises physicians to approach investing carefully, particularly emphasizing the importance of familiarity with healthcare-specific dynamics.
Ultimately, Moole believes that healthcare professionals possess a unique advantage in navigating investment decisions within their field, opening avenues to impactful contributions beyond traditional investing roles.
Why this story matters: The insights could enhance physician involvement in healthcare investments, addressing gaps in clinical understanding.
Key takeaway: Physicians have a structural advantage in venture capital due to their domain-specific knowledge.
Opposing viewpoint: Some may argue that venture capital investing is too risky and complex for those outside financial sectors.
